Baskerville E, Twarog R
J Bacteriol. 1974 Mar;117(3):1184-94. doi: 10.1128/jb.117.3.1184-1194.1974.
The anthranilate synthetase of Clostridium butyricum is composed of two nonidentical subunits of unequal size. An enzyme complex consisting of both subunits is required for glutamine utilization in the formation of anthranilic acid. Formation of anthranilate will proceed in the presence of partially pure subunit I provided ammonia is available in place of glutamine. Partially pure subunit II neither catalyzes the formation of anthranilate nor possesses anthranilate-5-phosphoribosylpyrophosphate phosphoribosyltransferase activity. The enzyme complex is stabilized by high subunit concentrations and by the presence of glutamine. High KCl concentrations promote dissociation of the enzyme into its component subunits. The synthesis of subunits I and II is coordinately controlled with the synthesis of the enzymes mediating reactions 4 and 5 of the tryptophan pathway. When using gel filtration procedures, the molecular weights of the large (I) and small (II) subunits were estimated to be 127,000 and 15,000, respectively. Partially pure anthranilate synthetase subunits were obtained from two spontaneous mutants resistant to growth inhibition by 5-methyltryptophan. One mutant, strain mtr-8, possessed an anthranilate synthetase that was resistant to feedback inhibition by tryptophan and by three tryptophan analogues: 5-methyl-tryptophan, 4- and 5-fluorotryptophan. Reconstruction experiments carried out by using partially purified enzyme subunits obtained from wild-type, mutant mtr-8 and mutant mtr-4 cells indicate that resistance of the enzyme from mutant mtr-8 to feedback inhibition by tryptophan or its analogues was the result of an alteration in the large (I) subunit. Mutant mtr-8 incorporates [(14)C]tryptophan into cell protein at a rate comparable with wild-type cells. Mutant mtr-4 failed to incorporate significant amounts of [(14)C]tryptophan into cell protein. We conclude that strain mtr-4 is resistant to growth inhibition by 5-methyltryptophan because it fails to transport the analogue into the cell. Although mutant mtr-8 was isolated as a spontaneous mutant having two different properties (altered regulatory properties and an anthranilate synthetase with altered sensitivity to feedback inhibition), we have no direct evidence that this was the result of a single mutational event.
丁酸梭菌的邻氨基苯甲酸合成酶由两个大小不等、互不相同的亚基组成。在邻氨基苯甲酸形成过程中利用谷氨酰胺时,需要由这两个亚基组成的酶复合物。如果有氨可替代谷氨酰胺,那么在存在部分纯化的亚基I时,邻氨基苯甲酸的形成仍可进行。部分纯化的亚基II既不催化邻氨基苯甲酸的形成,也不具有邻氨基苯甲酸-5-磷酸核糖焦磷酸磷酸核糖转移酶活性。高浓度的亚基以及谷氨酰胺的存在可使酶复合物稳定。高浓度的氯化钾会促使该酶解离成其组成亚基。亚基I和II的合成与色氨酸途径中反应4和反应5的介导酶的合成受到协同调控。采用凝胶过滤法时,大亚基(I)和小亚基(II)的分子量估计分别为127,000和15,000。部分纯化的邻氨基苯甲酸合成酶亚基是从两个对5-甲基色氨酸生长抑制具有抗性的自发突变体中获得的。一个突变体,即菌株mtr-8,其邻氨基苯甲酸合成酶对色氨酸以及三种色氨酸类似物(5-甲基色氨酸、4-氟色氨酸和5-氟色氨酸)的反馈抑制具有抗性。利用从野生型、突变体mtr-8和突变体mtr-4细胞中获得的部分纯化的酶亚基进行的重组实验表明,突变体mtr-8的酶对色氨酸或其类似物反馈抑制的抗性是大亚基(I)发生改变的结果。突变体mtr-8将[¹⁴C]色氨酸掺入细胞蛋白的速率与野生型细胞相当。突变体mtr-4未能将大量的[¹⁴C]色氨酸掺入细胞蛋白。我们得出结论,菌株mtr-4对5-甲基色氨酸的生长抑制具有抗性是因为它无法将该类似物转运到细胞内。尽管突变体mtr-8是作为具有两种不同特性(调控特性改变以及邻氨基苯甲酸合成酶对反馈抑制的敏感性改变)的自发突变体分离得到的,但我们没有直接证据表明这是单个突变事件的结果。